European Patent Office

T 1212/97 (Immunoglobulin preparations/GENENTECH) vom 14.05.2001

Europäischer Rechtsprechungsidentifikator
ECLI:EP:BA:2001:T121297.20010514
Datum der Entscheidung
14. Mai 2001
Aktenzeichen
T 1212/97
Antrag auf Überprüfung von
-
Anmeldenummer
84302368.0
IPC-Klasse
C12N 15/13
Verfahrenssprache
Englisch
Verteilung
An die Kammervorsitzenden und -mitglieder verteilt (B)
Amtsblattfassungen
Keine AB-Links gefunden
Weitere Entscheidungen für diese Akte
-
Zusammenfassungen für diese Entscheidung
-
Bezeichnung der Anmeldung
Recombinant immunoglobulin preparations, methods for their preparation, DNA sequences, expression vectors and recombinant host cells therefor
Name des Antragstellers
Genentech, Inc., et al
Name des Einsprechenden
Bristol-Myers Company
Roche Diagnostics GmbH
Protein Design
Ortho Pharmaceutical Corp.
Celltech Limited
Kammer
3.3.04
Leitsatz
-
Schlagwörter
Oral presentation - state of the art (no)
Main request - claim 1 - sufficiency of disclosure (no)
Main request - claim 16 - novelty (no)
First auxiliary request - claim 1- sufficiency of disclosure (no)
Second auxiliary request - novelty (yes)
Inventive step (yes)
Adaptation of the description
Orientierungssatz
The information content made publicly available by a lecture cannot be put beyond reasonable doubt by any evidence of the lecturer alone, as the lecturer is in a quite different position to a member of the audience (see point 3 ff).

ORDER

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The Appellant's main and first auxiliary requests are refused.

3. The claim of the second auxiliary claim request meets the requirements of the European Patent Convention.

4. The matter is remitted to the first instance with the order to maintain the patent on the basis of the claim of the second auxiliary request submitted at oral proceedings on 26 May 2000, pages 1 to 23 of the description submitted as auxiliary request at oral proceedings on 14 May 2001, and the drawings as granted.

5. The request for re-imbursement of the appeal fee is refused.